Cuba conducts phase III clinical trial for ataxia type two drug

A phase III clinical trial to evaluate the efficacy and safety of the nasal administration of NeuroEPO in adult patients with spinocerebellar ataxias is being successfully developed in Cuba.
- Written by Redacción ¡ahora!
- Category: Health
- Hits: 1650
The Latin American School of Medicine in Cuba (ELAM) and the Medicine major received the international accreditation granted by the Council for International Evaluation and Accreditation (ICAAE), the Ministry of Public Health confirmed on Wednesday.